Drug Approval | December 06, 2023
Zydus receives final approval from the USFDA for Ivabradine Tablets
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
GMM Pfaudler US completes acquisition of MixPro
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
India had proposed for setting up the global standards for millets
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The product has been in-licensed from Strides and will be commercialized by Amneal
The company has received Form 483 with three observations
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Subscribe To Our Newsletter & Stay Updated
